Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777712 · ClinicalTrials.gov registry record
Mechanisms Underlying Impaired Diabetic Wound Healing
A clinical trial of Diabetes and Non-healing Wounds, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 250
- Enrollment target
- 5
- Study locations
NCT00777712: Recruiting study of Diabetes and Non-healing Wounds, sponsored by University of Pittsburgh.
NCT00777712 is a study of Diabetes and Non-healing Wounds that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 250 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00777712, a study of Diabetes and Non-healing Wounds, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 5
- Study locations
Study Summary
The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus wound derived cells will also be studied.
Primary Outcome
Wound healing status
Conditions Studied
Interventions
- OTHER Blood draw
Study Locations (5)
Pennsylvania
- University of Pittsburgh - McKeesport - Pittsburgh
- University of Pittsburgh - Mercy - Pittsburgh
- University of Pittsburgh - Passavant - Pittsburgh
Indiana
- Comprehensive Wound Care Centers - Indianapolis
Ohio
- Comprehensive Wound Care Centers - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2008-09-01 |
| Est. Completion | 2030-12-31 |
What NCT00777712 shows while recruiting
NCT00777712 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT00777712 lists 5 locations in 3 states (Pennsylvania, Indiana, Ohio).
Frequently Asked Questions
What is clinical trial NCT00777712 about?
NCT00777712 is a clinical study titled "Mechanisms Underlying Impaired Diabetic Wound Healing". The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus w...
What is the current status of trial NCT00777712?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2008-09-01. Estimated completion is 2030-12-31.
What conditions does trial NCT00777712 study?
This clinical trial studies the following conditions: Diabetes, Non-healing Wounds.
What interventions are being tested in trial NCT00777712?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT00777712?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00777712 being conducted?
This trial has 5 study locations across Indiana, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00777712's enrollment target sits among peer trials
250 125th of 338 higher than 211 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
- NCT02021604 · 250 participants · Phase 1
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI